3P Biopharmaceuticals is a leading European CDMO specializing in the process development and GMP manufacturing of biologics products using microbial and mammalian expression systems.

3P Biopharmaceuticals offers solutions for biologics at all stages of product development: from research and development, all through the preclinical and clinical phases to commercial supply.

During more than 12 years of its performance 3P Biopharmaceuticals has worked with more than 50 different recombinant proteins and other biologics. It can support biologics with process and analytics development, DS and DP testing, release and stability, as well as GMP material supply for clinical trials and market.